Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

The Theralase AGM...

...will be held on June 19, 2024. Theralase AGM

April 22, 2024

V.TLT

FDA Decision on ImmunityBio's Anktiva tomorrow?

The deadline for FDA review of Anktiva (N-803) is tomorrow - April 23. If...

April 22, 2024

V.TLT

RE:Enhancing cancer immunotherapy with photodynamic therapy

This article would be much improved if only the authors were familiar with Dr...

April 22, 2024

T.PYR

RE:RE:RE:RE:RE:Tamaractock

I know for a fact that the claims sumpineh makes here are absolutely false...

April 22, 2024

V.TLT

RE:RE:Simple and Elegant...

Thanks for that Mikee3003. It's great to hear a recovery story...

April 16, 2024

V.TLT

The Sincerest Form of Flattery...

Chinese researchers have created some new compounds that have a structure...

April 16, 2024

V.TLT

RE:RE:RE:RE:RE:RE:Huge Global Blood Cancer Market

If our trial results remain good and durability of response remains high, it&...

April 10, 2024

V.TLT

Research at McFarland Labs Continues...

Alisher Talgatov, a 2nd year Ph.D. student, presents research on a new family...

April 10, 2024

V.TLT

Huge Global Blood Cancer Market

Today's Stockhouse article lays it all out: This company’s Photo...

April 9, 2024

V.TLT

How To Build A Cancer Vaccine Using PDT

Theralase's patent application contains information on how they intend to...

April 8, 2024

V.TLT

Durable Response Rate to beat at 36 months

Currently Adstiladrin is the best available FDA approved treatment for...

April 8, 2024

V.TLT

Confefence Call Transcript

Theralase Technologies Inc. (TLTFF) Q4 2023 Earnings Call Transcript...

April 7, 2024

V.TLT

RE:cancer is a disease that dody itself cannot recognise to

https://theralase.com/theralase-discovers-new-anti-cancer-vaccine/ https...

April 5, 2024

V.TLT

RE:TLT.. NOT A ONE TRICK PONY

It would be fantastic to see Theralase planning an actual trial for ...

April 5, 2024

V.TLT

UTA - Discover Student Research 2024 – Symposium

Meanwhile, back at the lab, research continues. With better financing maybe...

April 5, 2024

V.TLT

FDA Advice on Data Monitoring Committees in Clinical Trials

As it happens the FDA put out a new draft document in February 2024. It seems...

April 1, 2024

V.TLT

RE:RE:RE:Safety is more important...

There's a thought! If they get AA along with BTD, finishing the trial...

March 31, 2024

V.TLT

RE:RE:RE:RE:RE:RE:Is she saying that TLT can get fund rather than PP in 2024?

If Theralase finds an alternate means of funding will this dis-incentivize...

March 29, 2024

V.TLT

Anybody in Bangalore on Tuesday?

Special Seminar: Investigating the excited-state dynamics of a ruthenium...

March 29, 2024

V.TLT

RE:Data

I totally agree. The high efficacy, durable response, limited number of...

March 28, 2024

Featured Company